Phase III Study to Assess the Efficacy and Safety of SK3530 in Patients With Erectile Dysfunction and Hypertension

Phase 3 Completed 109 enrolled SK Chemicals Co., Ltd.

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of SK3530 in men with ED and hypertension who were taking antihypertensive medication.

Timeline

Start: 2007-12
Primary completion: 2008-09
Completion: 2008-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Mirodenafil	Small molecule	100 mg	—

Phase III Study to Assess the Efficacy and Safety of SK3530 in Patients With Erectile Dysfunction and Hypertension

Summary

Timeline

Drugs

Indications